<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01874652</url>
  </required_header>
  <id_info>
    <org_study_id>0007-13-BNZ</org_study_id>
    <nct_id>NCT01874652</nct_id>
  </id_info>
  <brief_title>Assessment of Safety &amp; Efficacy of Light Weight Breast Implant</brief_title>
  <official_title>Assessment of Safety &amp; Efficacy of Light Weight Breast Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate safety and effectiveness of Light Weight Breast&#xD;
      Implant (LWBI) in breast augmentation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Single-center. The purpose of the study is to evaluate safety and effectiveness of&#xD;
      LWBI in breast augmentation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>No reoperation</measure>
    <time_frame>during 6 months follow up period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration for all adverse events (AEs) on per patient and per implant basis will be recorded and analyzed.</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Breast Implants</condition>
  <arm_group>
    <arm_group_label>Light Weight Breast Implants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of Safety and Efficacy of Light Weight Breast Implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Light Weight Breast Implants</intervention_name>
    <description>Light Weight Breast Implants</description>
    <arm_group_label>Light Weight Breast Implants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Genetic women at ages 18 to 65 seeking breast enlargement&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Agreement to complete all required follow up visits&#xD;
&#xD;
          -  A medically acceptable candidate&#xD;
&#xD;
          -  Sufficient breast tissue for proper implant coverage (â‰¥20 mm by pinch test)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with active infection anywhere in their body&#xD;
&#xD;
          -  Women who are currently pregnant or nursing&#xD;
&#xD;
          -  Insufficient tissue covering in the prospective area of implantation (e.g. after&#xD;
             preceding breast reduction), radiation damage or reduced vascularization&#xD;
&#xD;
          -  Abscesses, malignant tumors(cancer or recurrent metastases), advanced fibrocystic&#xD;
             diseases&#xD;
&#xD;
          -  Patients with a history of psychiatric treatment&#xD;
&#xD;
          -  Patients that been implanted with any silicone implant (e.g. silicone artificial&#xD;
             joints, facial implants)&#xD;
&#xD;
          -  Expected allergies or extraordinary immune response to implants&#xD;
&#xD;
          -  Wound healing impairments or heavy burn scars&#xD;
&#xD;
          -  Existing costal injuries&#xD;
&#xD;
          -  The Patient Participated in an investigational trial within 30 days of enrollment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noam Calderon, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bnai-Zion</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bnai Zion</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <study_first_submitted>May 23, 2013</study_first_submitted>
  <study_first_submitted_qc>June 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2013</study_first_posted>
  <last_update_submitted>November 2, 2015</last_update_submitted>
  <last_update_submitted_qc>November 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

